ReviewDrugs & aging2019

Precautions and Monitoring of Patients Taking Phosphodiesterase Type 5 Inhibitors Who are at Risk of Increased Intraocular Pressure.

Joshua C Baker et al.PubMed ↗Publisher ↗

No numbers read from the abstract.